AAAAAA
Results:
1-20
|
Results: 20
Authors:
Gaillard, PJ
van der Meide, PH
de Boer, AG
Breimer, DD
Citation: Pj. Gaillard et al., Glucocorticoid and type I interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis, NEUROREPORT, 12(10), 2001, pp. 2189-2193
Active efflux of the 5-HT1A receptor agonist flesinoxan via P-glycoproteinat the blood-brain barrier
Authors:
van der Sandt, ICJ
Smolders, R
Nabulsi, L
Zuideveld, KP
de Boer, AG
Breimer, DD
Citation: Icj. Van Der Sandt et al., Active efflux of the 5-HT1A receptor agonist flesinoxan via P-glycoproteinat the blood-brain barrier, EUR J PH SC, 14(1), 2001, pp. 81-86
Authors:
Gaillard, PJ
Voorwinden, LH
Nielsen, JL
Ivanov, A
Atsumi, R
Engman, H
Ringbom, C
de Boer, AG
Breimer, DD
Citation: Pj. Gaillard et al., Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelialcells and astrocytes, EUR J PH SC, 12(3), 2001, pp. 215-222
Authors:
van der Sandt, ICJ
Gaillard, PJ
Voorwinden, HH
de Boer, AG
Breimer, DD
Citation: Icj. Van Der Sandt et al., P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier, PHARM RES, 18(5), 2001, pp. 587-592
Authors:
van der Sandt, ICJ
Vos, CMP
Nabulsi, L
Blom-Roosemalen, MCM
Voorwinden, HH
de Boer, AG
Breimer, DD
Citation: Icj. Van Der Sandt et al., Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood-brain barrier, AIDS, 15(4), 2001, pp. 483-491
Authors:
Karssen, AM
Meijer, OC
van der Sandt, ICJ
Lucassen, PJ
de Lange, ECM
de Boer, AG
de Kloet, ER
Citation: Am. Karssen et al., Multidrug resistance P-glycoprotein hampers the access of cortisol but notof corticosterone to mouse and human brain, ENDOCRINOL, 142(6), 2001, pp. 2686-2694
Authors:
Florea, BI
van der Sandt, ICJ
Schrier, SM
Kooiman, K
Deryckere, K
de Boer, AG
Junginger, HE
Borchard, G
Citation: Bi. Florea et al., Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3), BR J PHARM, 134(7), 2001, pp. 1555-1563
Authors:
de Lange, ECM
Marchand, S
van den Berg, DJ
van der Sandt, ICJ
de Boer, AG
Delon, A
Bouquet, S
Couet, W
Citation: Ecm. De Lange et al., In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin, EUR J PH SC, 12(2), 2000, pp. 85-93
Authors:
Gaillard, PJ
de Boer, AG
Citation: Pj. Gaillard et Ag. De Boer, Relationship between permeability status of the blood-brain barrier and invitro permeability coefficient of a drug, EUR J PH SC, 12(2), 2000, pp. 95-102
Authors:
van der Sandt, ICJ
Blom-Roosemalen, MCM
de Boer, AG
Breimer, DD
Citation: Icj. Van Der Sandt et al., Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1 : MDR1 and Caco-2 cell lines, EUR J PH SC, 11(3), 2000, pp. 207-214
Authors:
Gaillard, PJ
van der Sandt, ICJ
Voorwinden, LH
Vu, D
Nielsen, JL
de Boer, AG
Breimer, DD
Citation: Pj. Gaillard et al., Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier, PHARM RES, 17(10), 2000, pp. 1198-1205
Authors:
de Lange, ECM
de Boer, AG
Breimer, DD
Citation: Ecm. De Lange et al., Methodological issues in microdialysis sampling for pharmacokinetic studies, ADV DRUG DE, 45(2-3), 2000, pp. 125-148
Authors:
Thanou, MM
Kotze, AF
Scharringhausen, T
Luessen, HL
de Boer, AG
Verhoef, JC
Junginger, HE
Citation: Mm. Thanou et al., Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers, J CONTR REL, 64(1-3), 2000, pp. 15-25
Authors:
de Boer, AG
de Lange, ECM
van der Sandt, ICJ
Breimer, DD
Citation: Ag. De Boer et al., The application of microdialysis techniques to the study of drug transportacross the blood-brain barrier, BLOOD-BRAIN BARRIER AND DRUG DELIVERY TO THE CNS, 2000, pp. 77-92
Authors:
de Boer, AG
Gaillard, PJ
Breimer, DD
Citation: Ag. De Boer et al., The transference of results between blood-brain barrier cell culture systems, EUR J PH SC, 8(1), 1999, pp. 1-4
Authors:
Kotze, AF
Luessen, HL
de Boer, AG
Verhoef, JC
Junginger, HE
Citation: Af. Kotze et al., Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environments, EUR J PH SC, 7(2), 1999, pp. 145-151
Authors:
Kotze, AF
Thanou, MM
Lueben, HL
de Boer, AG
Verhoef, JC
Junginger, HE
Citation: Af. Kotze et al., Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: In vitro evaluation in intestinal epithelial cells (Caco-2), J PHARM SCI, 88(2), 1999, pp. 253-257
Authors:
Xie, RJ
Hammarlund-Udenaes, M
de Boer, AG
de Lange, ECM
Citation: Rj. Xie et al., The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+)mice, BR J PHARM, 128(3), 1999, pp. 563-568
Authors:
Luessen, HL
Verhoef, JC
de Boer, AG
Junginger, HE
de Leeuw, BJ
Borchard, G
Lehr, CM
Citation: Hl. Luessen et al., Multifunctional polymers for the peroral delivery of peptide drugs, DRUG PHARM, 98, 1999, pp. 299-339
Chitosan and chitosan derivatives as absorption enhancers for peptide drugs across mucosal epithelia
Authors:
Kotze, AF
Luessen, HL
Thanou, M
Verhoef, JC
de Boer, AG
Junginger, HE
Lehr, CM
Citation: Af. Kotze et al., Chitosan and chitosan derivatives as absorption enhancers for peptide drugs across mucosal epithelia, DRUG PHARM, 98, 1999, pp. 341-386
Risultati:
1-20
|